Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

BUY
$0.66 - $259.46 $17,117 - $6.73 Million
25,935 Added 155.1%
42,657 $29,000
Q3 2022

Oct 07, 2022

BUY
$0.65 - $278.68 $1,141 - $489,362
1,756 Added 11.73%
16,722 $17,000
Q2 2022

Jul 20, 2022

BUY
$0.51 - $0.93 $5,908 - $10,774
11,585 Added 342.65%
14,966 $10,000
Q1 2022

Apr 26, 2022

BUY
$0.84 - $1.71 $2,840 - $5,781
3,381 New
3,381 $3,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $117M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.